SJS Investment Consulting’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
SJS Investment Consulting's WST Position: Q3 2026 in Review
SJS Investment Consulting increased its West Pharmaceutical (WST) stake by 1.7% in Q3 2026, buying an estimated $706 and bringing the position to 120 shares worth $44.5K. The position accounts for ﹤0.01% of the portfolio, ranked #702.
SJS Investment Consulting first reported a position in WST in Q1 2022 and has held it in 18 quarters since. The position peaked at $50.1K in Q4 2025. 813 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- SJS Investment Consulting held 120 shares of West Pharmaceutical worth $44.5K as of Q3 2026.
- SJS Investment Consulting bought 2 West Pharmaceutical shares in Q3 2026, an estimated $706.
- West Pharmaceutical made up ﹤0.01% of SJS Investment Consulting's portfolio in Q3 2026, its #702 holding.
- SJS Investment Consulting first reported a position in West Pharmaceutical in Q1 2022 and has held it in 18 quarters since.
- SJS Investment Consulting's West Pharmaceutical position peaked at $50.1K in Q4 2025.
- 813 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.